178 related articles for article (PubMed ID: 17878956)
1. The 14-3-3zeta-GPIb-IX-V complex as an antiplatelet target.
Andrews RK; Du X; Berndt MC
Drug News Perspect; 2007 Jun; 20(5):285-92. PubMed ID: 17878956
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
3. A functional 14-3-3zeta-independent association of PI3-kinase with glycoprotein Ib alpha, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex.
Mu FT; Andrews RK; Arthur JF; Munday AD; Cranmer SL; Jackson SP; Stomski FC; Lopez AF; Berndt MC
Blood; 2008 May; 111(9):4580-7. PubMed ID: 18299448
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3zeta binding to GpIb/IX/V.
Feng S; Christodoulides N; Reséndiz JC; Berndt MC; Kroll MH
Blood; 2000 Jan; 95(2):551-7. PubMed ID: 10627461
[TBL] [Abstract][Full Text] [Related]
5. A critical role for 14-3-3zeta protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications.
Dai K; Bodnar R; Berndt MC; Du X
Blood; 2005 Sep; 106(6):1975-81. PubMed ID: 15941906
[TBL] [Abstract][Full Text] [Related]
6. Functional association of phosphoinositide-3-kinase with platelet glycoprotein Ibalpha, the major ligand-binding subunit of the glycoprotein Ib-IX-V complex.
Mu FT; Cranmer SL; Andrews RK; Berndt MC
J Thromb Haemost; 2010 Feb; 8(2):324-30. PubMed ID: 19874472
[TBL] [Abstract][Full Text] [Related]
7. Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb.
Peng M; Emig FA; Mao A; Lu W; Kirby EP; Niewiarowski S; Kowalska MA
Thromb Haemost; 1995 Sep; 74(3):954-7. PubMed ID: 8571328
[TBL] [Abstract][Full Text] [Related]
8. The platelet glycoprotein Ib-V-IX system: regulation of gene expression.
Roth GJ; Yagi M; Bastian LS
Stem Cells; 1996; 14 Suppl 1():188-93. PubMed ID: 11012220
[TBL] [Abstract][Full Text] [Related]
9. Role of 14-3-3ζ in platelet glycoprotein Ibα-von Willebrand factor interaction-induced signaling.
Zhang W; Zhao L; Liu J; Du J; Yan R; Dai K
Int J Mol Sci; 2012; 13(5):5364-5374. PubMed ID: 22754302
[TBL] [Abstract][Full Text] [Related]
10. Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex.
Andrews RK; Munday AD; Mitchell CA; Berndt MC
Blood; 2001 Aug; 98(3):681-7. PubMed ID: 11468167
[TBL] [Abstract][Full Text] [Related]
11. The phytotoxin fusicoccin promotes platelet aggregation via 14-3-3-glycoprotein Ib-IX-V interaction.
Camoni L; Di Lucente C; Visconti S; Aducci P
Biochem J; 2011 Jun; 436(2):429-36. PubMed ID: 21395556
[TBL] [Abstract][Full Text] [Related]
12. A novel missense mutation shows that GPIbbeta has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor.
Strassel C; Pasquet JM; Alessi MC; Juhan-Vague I; Chambost H; Combrié R; Nurden P; Bas MJ; De La Salle C; Cazenave JP; Lanza F; Nurden AT
Biochemistry; 2003 Apr; 42(15):4452-62. PubMed ID: 12693941
[TBL] [Abstract][Full Text] [Related]
13. Identification of a binding sequence for the 14-3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ib alpha.
Du X; Fox JE; Pei S
J Biol Chem; 1996 Mar; 271(13):7362-7. PubMed ID: 8631758
[TBL] [Abstract][Full Text] [Related]
14. Human signaling protein 14-3-3zeta interacts with platelet glycoprotein Ib subunits Ibalpha and Ibbeta.
Calverley DC; Kavanagh TJ; Roth GJ
Blood; 1998 Feb; 91(4):1295-303. PubMed ID: 9454760
[TBL] [Abstract][Full Text] [Related]
15. Soy Isoflavones Inhibit Both GPIb-IX Signaling and αIIbβ3 Outside-In Signaling via 14-3-3ζ in Platelet.
Liu M; Wang G; Xu R; Shen C; Ni H; Lai R
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443497
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis.
Bonnefoy A; Vermylen J; Hoylaerts MF
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):257-69. PubMed ID: 15030285
[TBL] [Abstract][Full Text] [Related]
17. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
18. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous loss of platelet glycoprotein (GP) Ib-V-IX variably affects platelet function in velocardiofacial syndrome (VCFS) patients.
Liang HP; Morel-Kopp MC; Curtin J; Wilson M; Hewson J; Chen W; Ward CM
Thromb Haemost; 2007 Dec; 98(6):1298-308. PubMed ID: 18064328
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel 14-3-3zeta binding site within the cytoplasmic tail of platelet glycoprotein Ibalpha.
Mangin P; David T; Lavaud V; Cranmer SL; Pikovski I; Jackson SP; Berndt MC; Cazenave JP; Gachet C; Lanza F
Blood; 2004 Jul; 104(2):420-7. PubMed ID: 15054037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
